SLNO

STRONG

SOLENO THERAPEUTICS INC

CIK: 0001484565

Sell (70% confidence)

Last activity: 1 weeks ago

Financial Metrics

As of Dec 31, 2025 (10-K)

Revenue $1.45M

Total Cash $70.11M

Current Ratio 5.80

Insider	Buys	Sells	Net Value	Holdings
Manning Meredith Chief Commercial Officer	0	3	-$229K	67,165 shares $2.02M
Huang Michael F. Sr. VP of Clinical Development	0	3	-$200K	42,149 shares $1.27M

SELL Manning Meredith (Chief Commercial Officer)

4,864 shares @ $30.04

$146K

Mar 27, 2026

Conviction: | View SEC Filing →

SELL Huang Michael F. (Sr. VP of Clinical Development)

4,256 shares @ $30.04

$128K

Mar 27, 2026

Conviction: | View SEC Filing →

SELL Manning Meredith (Chief Commercial Officer)

2,100 shares @ $31.04

$65K

Mar 27, 2026

Conviction: | View SEC Filing →

SELL Huang Michael F. (Sr. VP of Clinical Development)

1,838 shares @ $31.04

$57K

Mar 27, 2026

Conviction: | View SEC Filing →

SELL Manning Meredith (Chief Commercial Officer)

558 shares @ $31.72

$18K

Mar 27, 2026

Conviction: | View SEC Filing →

SELL Huang Michael F. (Sr. VP of Clinical Development)

488 shares @ $31.72

$15K

Mar 27, 2026

Conviction: | View SEC Filing →

• This is AI-generated analysis for educational purposes only, not financial advice.

• Insider trading data is derived from SEC Form 4 filings and may contain errors.

• Always conduct your own research and consult qualified financial advisors before making investment decisions.